184 related articles for article (PubMed ID: 36288906)
1. A Deficiency in the Cytokine TNFSF14/LIGHT Limits Inflammation and Remodeling in Murine Eosinophilic Esophagitis.
Manresa MC; Miki H; Miller J; Okamoto K; Dobaczewska K; Herro R; Gupta RK; Kurten R; Aceves SS; Croft M
J Immunol; 2022 Oct; ():. PubMed ID: 36288906
[TBL] [Abstract][Full Text] [Related]
2. A Deficiency in the Cytokine TNFSF14/LIGHT Limits Inflammation and Remodeling in Murine Eosinophilic Esophagitis.
Manresa MC; Miki H; Miller J; Okamoto K; Dobaczewska K; Herro R; Gupta RK; Kurten R; Aceves SS; Croft M
J Immunol; 2022 Oct; ():. PubMed ID: 36426994
[TBL] [Abstract][Full Text] [Related]
3. Increased Production of LIGHT by T Cells in Eosinophilic Esophagitis Promotes Differentiation of Esophageal Fibroblasts Toward an Inflammatory Phenotype.
Manresa MC; Chiang AWT; Kurten RC; Dohil R; Brickner H; Dohil L; Herro R; Akuthota P; Lewis NE; Croft M; Aceves SS
Gastroenterology; 2020 Nov; 159(5):1778-1792.e13. PubMed ID: 32712105
[TBL] [Abstract][Full Text] [Related]
4. TNF-related apoptosis-inducing ligand (TRAIL) regulates midline-1, thymic stromal lymphopoietin, inflammation, and remodeling in experimental eosinophilic esophagitis.
Collison AM; Sokulsky LA; Sherrill JD; Nightingale S; Hatchwell L; Talley NJ; Walker MM; Rothenberg ME; Mattes J
J Allergy Clin Immunol; 2015 Oct; 136(4):971-82. PubMed ID: 25981737
[TBL] [Abstract][Full Text] [Related]
5. LIGHT controls distinct homeostatic and inflammatory gene expression profiles in esophageal fibroblasts via differential HVEM and LTβR-mediated mechanisms.
Manresa MC; Wu A; Nhu QM; Chiang AWT; Okamoto K; Miki H; Kurten R; Pham E; Duong LD; Lewis NE; Akuthota P; Croft M; Aceves SS
Mucosal Immunol; 2022 Feb; 15(2):327-337. PubMed ID: 34903876
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of allergen-induced eosinophilic esophagitis is independent of interleukin (IL)-13.
Niranjan R; Rayapudi M; Mishra A; Dutt P; Dynda S; Mishra A
Immunol Cell Biol; 2013 Jul; 91(6):408-15. PubMed ID: 23689305
[TBL] [Abstract][Full Text] [Related]
7. Tissue remodeling in eosinophilic esophagitis.
Cheng E; Souza RF; Spechler SJ
Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(11):G1175-87. PubMed ID: 23019192
[TBL] [Abstract][Full Text] [Related]
8. Antifibrotic Effects of the Thiazolidinediones in Eosinophilic Esophagitis Pathologic Remodeling: A Preclinical Evaluation.
Nhu QM; Hsieh L; Dohil L; Dohil R; Newbury RO; Kurten R; Moawad FJ; Aceves SS
Clin Transl Gastroenterol; 2020 Apr; 11(4):e00164. PubMed ID: 32352681
[TBL] [Abstract][Full Text] [Related]
9. Scientific journey to the first FDA-approved drug for eosinophilic esophagitis.
Rothenberg ME
J Allergy Clin Immunol; 2022 Dec; 150(6):1325-1332. PubMed ID: 36209816
[TBL] [Abstract][Full Text] [Related]
10. Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33-basophil axis in mice.
Venturelli N; Lexmond WS; Ohsaki A; Nurko S; Karasuyama H; Fiebiger E; Oyoshi MK
J Allergy Clin Immunol; 2016 Nov; 138(5):1367-1380.e5. PubMed ID: 27233150
[TBL] [Abstract][Full Text] [Related]
11. Esophageal functional impairments in experimental eosinophilic esophagitis.
Mavi P; Rajavelu P; Rayapudi M; Paul RJ; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2012 Jun; 302(11):G1347-55. PubMed ID: 22361731
[TBL] [Abstract][Full Text] [Related]
12. Targeting AMCase reduces esophageal eosinophilic inflammation and remodeling in a mouse model of egg induced eosinophilic esophagitis.
Cho JY; Rosenthal P; Miller M; Pham A; Aceves S; Sakuda S; Broide DH
Int Immunopharmacol; 2014 Jan; 18(1):35-42. PubMed ID: 24239745
[TBL] [Abstract][Full Text] [Related]
13. TRAIL deficiency and PP2A activation with salmeterol ameliorates egg allergen-driven eosinophilic esophagitis.
Sokulsky LA; Collison AM; Nightingale S; Fevre AL; Percival E; Starkey MR; Hansbro PM; Foster PS; Mattes J
Am J Physiol Gastrointest Liver Physiol; 2016 Dec; 311(6):G998-G1008. PubMed ID: 27742702
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic Esophagitis-Associated Chemical and Mechanical Microenvironment Shapes Esophageal Fibroblast Behavior.
Muir AB; Dods K; Henry SJ; Benitez AJ; Lee D; Whelan KA; DeMarshall M; Hammer DA; Falk G; Wells RG; Spergel J; Nakagawa H; Wang ML
J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):200-9. PubMed ID: 26727658
[TBL] [Abstract][Full Text] [Related]
15. Elevated IL-33 expression is associated with pediatric eosinophilic esophagitis, and exogenous IL-33 promotes eosinophilic esophagitis development in mice.
Judd LM; Heine RG; Menheniott TR; Buzzelli J; O'Brien-Simpson N; Pavlic D; O'Connor L; Al Gazali K; Hamilton O; Scurr M; Collison AM; Mattes J; Allen KJ; Giraud AS
Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G13-25. PubMed ID: 26514775
[TBL] [Abstract][Full Text] [Related]
16. Epithelial cell-expressed type II IL-4 receptor mediates eosinophilic esophagitis.
Avlas S; Shani G; Rhone N; Itan M; Dolitzky A; Hazut I; Grisaru-Tal S; Gordon Y; Shoda T; Ballaban A; Ben-Baruch NM; Rochman M; Diesendruck Y; Nahary L; Bitton A; Halpern Z; Benhar I; Varol C; Rothenberg ME; Munitz A
Allergy; 2023 Feb; 78(2):464-476. PubMed ID: 36070083
[TBL] [Abstract][Full Text] [Related]
17. Targeting granulocyte-macrophage colony-stimulating factor in epithelial and vascular remodeling in experimental eosinophilic esophagitis.
McNamee EN; Biette KA; Hammer J; Harris R; Miyazawa H; Lee JJ; Furuta GT; Masterson JC
Allergy; 2017 Aug; 72(8):1232-1242. PubMed ID: 27926989
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-15 expression is increased in human eosinophilic esophagitis and mediates pathogenesis in mice.
Zhu X; Wang M; Mavi P; Rayapudi M; Pandey AK; Kaul A; Putnam PE; Rothenberg ME; Mishra A
Gastroenterology; 2010 Jul; 139(1):182-93.e7. PubMed ID: 20381491
[TBL] [Abstract][Full Text] [Related]
19. Loss of Endothelial TSPAN12 Promotes Fibrostenotic Eosinophilic Esophagitis via Endothelial Cell-Fibroblast Crosstalk.
Shoda T; Wen T; Caldwell JM; Ben-Baruch Morgenstern N; Osswald GA; Rochman M; Mack LE; Felton JM; Abonia JP; Arva NC; Atkins D; Bonis PA; Capocelli KE; Collins MH; Dellon ES; Falk GW; Gonsalves N; Gupta SK; Hirano I; Leung J; Menard-Katcher PA; Mukkada VA; Putnam PE; Rudman Spergel AK; Spergel JM; Wechsler JB; Yang GY; Aceves SS; Furuta GT; Rothenberg ME;
Gastroenterology; 2022 Feb; 162(2):439-453. PubMed ID: 34687736
[TBL] [Abstract][Full Text] [Related]
20. Functional role of kallikrein 5 and proteinase-activated receptor 2 in eosinophilic esophagitis.
Azouz NP; Klingler AM; Pathre P; Besse JA; Baruch-Morgenstern NB; Ballaban AY; Osswald GA; Brusilovsky M; Habel JE; Caldwell JM; Ynga-Durand MA; Abonia PJ; Hu YC; Wen T; Rothenberg ME
Sci Transl Med; 2020 May; 12(545):. PubMed ID: 32461336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
